nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—DRD4—alcohol dependence	0.397	0.626	CbGaD
L-DOPA—DRD2—alcohol dependence	0.237	0.374	CbGaD
L-DOPA—DDC—nerve—alcohol dependence	0.00315	0.0409	CbGeAlD
L-DOPA—PSIP1—brainstem—alcohol dependence	0.00237	0.0308	CbGeAlD
L-DOPA—DRD1—nerve—alcohol dependence	0.00232	0.03	CbGeAlD
L-DOPA—PSIP1—forebrain—alcohol dependence	0.00229	0.0297	CbGeAlD
L-DOPA—PSIP1—cardiovascular system—alcohol dependence	0.00194	0.0251	CbGeAlD
L-DOPA—PSIP1—gonad—alcohol dependence	0.00176	0.0228	CbGeAlD
L-DOPA—PSIP1—digestive system—alcohol dependence	0.00161	0.0209	CbGeAlD
L-DOPA—PSIP1—blood—alcohol dependence	0.00153	0.0199	CbGeAlD
L-DOPA—PSIP1—midbrain—alcohol dependence	0.00151	0.0196	CbGeAlD
L-DOPA—SLC7A8—forebrain—alcohol dependence	0.00151	0.0196	CbGeAlD
L-DOPA—DRD2—nerve—alcohol dependence	0.00137	0.0178	CbGeAlD
L-DOPA—DDC—brainstem—alcohol dependence	0.00135	0.0176	CbGeAlD
L-DOPA—PSIP1—endocrine gland—alcohol dependence	0.00133	0.0172	CbGeAlD
L-DOPA—DDC—forebrain—alcohol dependence	0.00131	0.0169	CbGeAlD
L-DOPA—PSIP1—testis—alcohol dependence	0.00127	0.0164	CbGeAlD
L-DOPA—DRD5—forebrain—alcohol dependence	0.00126	0.0163	CbGeAlD
L-DOPA—PSIP1—nervous system—alcohol dependence	0.00124	0.0161	CbGeAlD
L-DOPA—SLC7A8—pancreas—alcohol dependence	0.00124	0.0161	CbGeAlD
L-DOPA—PSIP1—liver—alcohol dependence	0.0012	0.0155	CbGeAlD
L-DOPA—PSIP1—central nervous system—alcohol dependence	0.0012	0.0155	CbGeAlD
L-DOPA—PSIP1—cerebellum—alcohol dependence	0.00117	0.0152	CbGeAlD
L-DOPA—SLC7A8—gonad—alcohol dependence	0.00116	0.015	CbGeAlD
L-DOPA—DRD4—testis—alcohol dependence	0.00105	0.0137	CbGeAlD
L-DOPA—DRD1—brainstem—alcohol dependence	0.000995	0.0129	CbGeAlD
L-DOPA—SLC7A5—cardiovascular system—alcohol dependence	0.000989	0.0128	CbGeAlD
L-DOPA—SLC7A5—pancreas—alcohol dependence	0.000962	0.0125	CbGeAlD
L-DOPA—DRD1—forebrain—alcohol dependence	0.00096	0.0124	CbGeAlD
L-DOPA—PSIP1—brain—alcohol dependence	0.000951	0.0123	CbGeAlD
L-DOPA—SLC7A5—gonad—alcohol dependence	0.000898	0.0116	CbGeAlD
L-DOPA—SLC7A8—endocrine gland—alcohol dependence	0.000876	0.0114	CbGeAlD
L-DOPA—DDC—midbrain—alcohol dependence	0.000863	0.0112	CbGeAlD
L-DOPA—SLC7A8—testis—alcohol dependence	0.000835	0.0108	CbGeAlD
L-DOPA—SLC7A5—digestive system—alcohol dependence	0.000821	0.0107	CbGeAlD
L-DOPA—SLC7A8—nervous system—alcohol dependence	0.00082	0.0106	CbGeAlD
L-DOPA—DRD4—brain—alcohol dependence	0.000791	0.0103	CbGeAlD
L-DOPA—SLC7A8—liver—alcohol dependence	0.00079	0.0102	CbGeAlD
L-DOPA—SLC7A8—central nervous system—alcohol dependence	0.000789	0.0102	CbGeAlD
L-DOPA—SLC7A5—blood—alcohol dependence	0.000783	0.0101	CbGeAlD
L-DOPA—SLC7A5—midbrain—alcohol dependence	0.000773	0.01	CbGeAlD
L-DOPA—SLC7A8—cerebellum—alcohol dependence	0.000771	0.01	CbGeAlD
L-DOPA—DDC—endocrine gland—alcohol dependence	0.000758	0.00983	CbGeAlD
L-DOPA—DRD5—endocrine gland—alcohol dependence	0.000729	0.00945	CbGeAlD
L-DOPA—DRD3—nervous system—alcohol dependence	0.000728	0.00944	CbGeAlD
L-DOPA—DDC—testis—alcohol dependence	0.000723	0.00937	CbGeAlD
L-DOPA—DDC—nervous system—alcohol dependence	0.000709	0.0092	CbGeAlD
L-DOPA—DRD3—central nervous system—alcohol dependence	0.000701	0.00909	CbGeAlD
L-DOPA—SLC16A10—gonad—alcohol dependence	0.000688	0.00892	CbGeAlD
L-DOPA—DDC—liver—alcohol dependence	0.000683	0.00886	CbGeAlD
L-DOPA—DDC—central nervous system—alcohol dependence	0.000683	0.00885	CbGeAlD
L-DOPA—DRD5—nervous system—alcohol dependence	0.000682	0.00884	CbGeAlD
L-DOPA—SLC15A1—digestive system—alcohol dependence	0.000682	0.00884	CbGeAlD
L-DOPA—SLC7A5—endocrine gland—alcohol dependence	0.000679	0.0088	CbGeAlD
L-DOPA—Dopamine—MAOB—alcohol dependence	0.000657	0.195	CrCbGaD
L-DOPA—DRD5—central nervous system—alcohol dependence	0.000657	0.00851	CbGeAlD
L-DOPA—Paraesthesia—Disulfiram—alcohol dependence	0.000652	0.00402	CcSEcCtD
L-DOPA—SLC7A5—testis—alcohol dependence	0.000647	0.00839	CbGeAlD
L-DOPA—Somnolence—Disulfiram—alcohol dependence	0.000646	0.00398	CcSEcCtD
L-DOPA—Gastritis—Acamprosate—alcohol dependence	0.000644	0.00398	CcSEcCtD
L-DOPA—Dyskinesia—Citalopram—alcohol dependence	0.00064	0.00395	CcSEcCtD
L-DOPA—SLC7A5—nervous system—alcohol dependence	0.000635	0.00824	CbGeAlD
L-DOPA—DRD1—midbrain—alcohol dependence	0.000634	0.00822	CbGeAlD
L-DOPA—Dysphagia—Acamprosate—alcohol dependence	0.000629	0.00388	CcSEcCtD
L-DOPA—SLC7A8—brain—alcohol dependence	0.000627	0.00812	CbGeAlD
L-DOPA—Fatigue—Disulfiram—alcohol dependence	0.000626	0.00386	CcSEcCtD
L-DOPA—Pain—Disulfiram—alcohol dependence	0.000621	0.00383	CcSEcCtD
L-DOPA—Cramp muscle—Naltrexone—alcohol dependence	0.00062	0.00383	CcSEcCtD
L-DOPA—Gait disturbance—Citalopram—alcohol dependence	0.000616	0.0038	CcSEcCtD
L-DOPA—Nasopharyngitis—Naltrexone—alcohol dependence	0.000616	0.0038	CcSEcCtD
L-DOPA—Angina pectoris—Acamprosate—alcohol dependence	0.000613	0.00378	CcSEcCtD
L-DOPA—Muscle twitching—Citalopram—alcohol dependence	0.000612	0.00378	CcSEcCtD
L-DOPA—SLC7A5—liver—alcohol dependence	0.000612	0.00794	CbGeAlD
L-DOPA—SLC7A5—central nervous system—alcohol dependence	0.000612	0.00793	CbGeAlD
L-DOPA—Musculoskeletal pain—Citalopram—alcohol dependence	0.000609	0.00375	CcSEcCtD
L-DOPA—Hiccups—Citalopram—alcohol dependence	0.000601	0.00371	CcSEcCtD
L-DOPA—SLC16A10—blood—alcohol dependence	0.000599	0.00777	CbGeAlD
L-DOPA—SLC7A5—cerebellum—alcohol dependence	0.000598	0.00775	CbGeAlD
L-DOPA—DRD2—brainstem—alcohol dependence	0.000588	0.00762	CbGeAlD
L-DOPA—Salivary hypersecretion—Citalopram—alcohol dependence	0.000584	0.0036	CcSEcCtD
L-DOPA—Pollakiuria—Acamprosate—alcohol dependence	0.000581	0.00359	CcSEcCtD
L-DOPA—Nightmare—Citalopram—alcohol dependence	0.000581	0.00358	CcSEcCtD
L-DOPA—Urinary incontinence—Citalopram—alcohol dependence	0.000581	0.00358	CcSEcCtD
L-DOPA—Sweating increased—Naltrexone—alcohol dependence	0.00058	0.00358	CcSEcCtD
L-DOPA—Angina pectoris—Naltrexone—alcohol dependence	0.00058	0.00358	CcSEcCtD
L-DOPA—Weight increased—Acamprosate—alcohol dependence	0.000573	0.00353	CcSEcCtD
L-DOPA—Weight decreased—Acamprosate—alcohol dependence	0.000569	0.00351	CcSEcCtD
L-DOPA—DRD2—forebrain—alcohol dependence	0.000567	0.00735	CbGeAlD
L-DOPA—SLC15A1—endocrine gland—alcohol dependence	0.000563	0.00731	CbGeAlD
L-DOPA—Depression—Acamprosate—alcohol dependence	0.00056	0.00345	CcSEcCtD
L-DOPA—DRD3—brain—alcohol dependence	0.000556	0.00721	CbGeAlD
L-DOPA—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.000553	0.00341	CcSEcCtD
L-DOPA—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000553	0.00341	CcSEcCtD
L-DOPA—Myocardial infarction—Acamprosate—alcohol dependence	0.00055	0.00339	CcSEcCtD
L-DOPA—Urinary tract infection—Acamprosate—alcohol dependence	0.000546	0.00336	CcSEcCtD
L-DOPA—DDC—brain—alcohol dependence	0.000542	0.00703	CbGeAlD
L-DOPA—Weight increased—Naltrexone—alcohol dependence	0.000542	0.00334	CcSEcCtD
L-DOPA—Weight decreased—Naltrexone—alcohol dependence	0.000539	0.00332	CcSEcCtD
L-DOPA—Depression—Naltrexone—alcohol dependence	0.000529	0.00327	CcSEcCtD
L-DOPA—Hyperkinesia—Citalopram—alcohol dependence	0.000525	0.00324	CcSEcCtD
L-DOPA—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000523	0.00323	CcSEcCtD
L-DOPA—Asthenia—Disulfiram—alcohol dependence	0.000521	0.00322	CcSEcCtD
L-DOPA—DRD5—brain—alcohol dependence	0.000521	0.00676	CbGeAlD
L-DOPA—DRD1—nervous system—alcohol dependence	0.000521	0.00676	CbGeAlD
L-DOPA—Myocardial infarction—Naltrexone—alcohol dependence	0.00052	0.00321	CcSEcCtD
L-DOPA—SLC16A10—endocrine gland—alcohol dependence	0.00052	0.00674	CbGeAlD
L-DOPA—Euphoric mood—Citalopram—alcohol dependence	0.000517	0.00319	CcSEcCtD
L-DOPA—Urinary tract infection—Naltrexone—alcohol dependence	0.000516	0.00318	CcSEcCtD
L-DOPA—SLC15A1—liver—alcohol dependence	0.000508	0.00659	CbGeAlD
L-DOPA—Phlebitis—Citalopram—alcohol dependence	0.000507	0.00313	CcSEcCtD
L-DOPA—Haemoglobin—Acamprosate—alcohol dependence	0.000506	0.00312	CcSEcCtD
L-DOPA—Rhinitis—Acamprosate—alcohol dependence	0.000505	0.00312	CcSEcCtD
L-DOPA—Sleep disorder—Citalopram—alcohol dependence	0.000504	0.00311	CcSEcCtD
L-DOPA—Haemorrhage—Acamprosate—alcohol dependence	0.000504	0.00311	CcSEcCtD
L-DOPA—DRD1—central nervous system—alcohol dependence	0.000502	0.00651	CbGeAlD
L-DOPA—Hallucination—Acamprosate—alcohol dependence	0.000501	0.00309	CcSEcCtD
L-DOPA—Hypoaesthesia—Acamprosate—alcohol dependence	0.000501	0.00309	CcSEcCtD
L-DOPA—SLC16A10—testis—alcohol dependence	0.000496	0.00643	CbGeAlD
L-DOPA—Dopamine—DRD4—alcohol dependence	0.000495	0.147	CrCbGaD
L-DOPA—Vascular purpura—Citalopram—alcohol dependence	0.000488	0.00301	CcSEcCtD
L-DOPA—Disorientation—Citalopram—alcohol dependence	0.000488	0.00301	CcSEcCtD
L-DOPA—SLC7A5—brain—alcohol dependence	0.000486	0.0063	CbGeAlD
L-DOPA—Haemolytic anaemia—Citalopram—alcohol dependence	0.000484	0.00298	CcSEcCtD
L-DOPA—Dizziness—Disulfiram—alcohol dependence	0.00048	0.00296	CcSEcCtD
L-DOPA—Hallucination—Naltrexone—alcohol dependence	0.000474	0.00293	CcSEcCtD
L-DOPA—SLC16A10—liver—alcohol dependence	0.000469	0.00608	CbGeAlD
L-DOPA—Hot flush—Citalopram—alcohol dependence	0.000467	0.00288	CcSEcCtD
L-DOPA—Menopausal symptoms—Citalopram—alcohol dependence	0.000463	0.00285	CcSEcCtD
L-DOPA—Dopamine—MAOA—alcohol dependence	0.000461	0.137	CrCbGaD
L-DOPA—Rash—Disulfiram—alcohol dependence	0.000458	0.00283	CcSEcCtD
L-DOPA—SLC16A10—cerebellum—alcohol dependence	0.000458	0.00594	CbGeAlD
L-DOPA—Dermatitis bullous—Citalopram—alcohol dependence	0.000457	0.00282	CcSEcCtD
L-DOPA—Headache—Disulfiram—alcohol dependence	0.000455	0.00281	CcSEcCtD
L-DOPA—Dopamine—HTR7—alcohol dependence	0.000454	0.135	CrCbGaD
L-DOPA—Purpura—Citalopram—alcohol dependence	0.000453	0.00279	CcSEcCtD
L-DOPA—Alopecia—Acamprosate—alcohol dependence	0.000445	0.00275	CcSEcCtD
L-DOPA—Mental disorder—Acamprosate—alcohol dependence	0.000441	0.00272	CcSEcCtD
L-DOPA—Pain in extremity—Citalopram—alcohol dependence	0.000437	0.00269	CcSEcCtD
L-DOPA—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000437	0.00269	CcSEcCtD
L-DOPA—Diplopia—Citalopram—alcohol dependence	0.000437	0.00269	CcSEcCtD
L-DOPA—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000433	0.00267	CcSEcCtD
L-DOPA—Flatulence—Acamprosate—alcohol dependence	0.000432	0.00267	CcSEcCtD
L-DOPA—Tension—Acamprosate—alcohol dependence	0.00043	0.00265	CcSEcCtD
L-DOPA—Dysgeusia—Acamprosate—alcohol dependence	0.000429	0.00265	CcSEcCtD
L-DOPA—Psychotic disorder—Citalopram—alcohol dependence	0.000426	0.00263	CcSEcCtD
L-DOPA—Nervousness—Acamprosate—alcohol dependence	0.000426	0.00263	CcSEcCtD
L-DOPA—Back pain—Acamprosate—alcohol dependence	0.000424	0.00262	CcSEcCtD
L-DOPA—Muscle spasms—Acamprosate—alcohol dependence	0.000422	0.0026	CcSEcCtD
L-DOPA—Alopecia—Naltrexone—alcohol dependence	0.000421	0.0026	CcSEcCtD
L-DOPA—Mental disorder—Naltrexone—alcohol dependence	0.000418	0.00258	CcSEcCtD
L-DOPA—Urinary retention—Citalopram—alcohol dependence	0.000415	0.00256	CcSEcCtD
L-DOPA—Tremor—Acamprosate—alcohol dependence	0.000411	0.00253	CcSEcCtD
L-DOPA—Ataxia—Citalopram—alcohol dependence	0.000411	0.00253	CcSEcCtD
L-DOPA—Flatulence—Naltrexone—alcohol dependence	0.000409	0.00252	CcSEcCtD
L-DOPA—Tension—Naltrexone—alcohol dependence	0.000407	0.00251	CcSEcCtD
L-DOPA—Ill-defined disorder—Acamprosate—alcohol dependence	0.000407	0.00251	CcSEcCtD
L-DOPA—Dysgeusia—Naltrexone—alcohol dependence	0.000406	0.00251	CcSEcCtD
L-DOPA—Anaemia—Acamprosate—alcohol dependence	0.000405	0.0025	CcSEcCtD
L-DOPA—Agitation—Acamprosate—alcohol dependence	0.000403	0.00249	CcSEcCtD
L-DOPA—Nervousness—Naltrexone—alcohol dependence	0.000403	0.00249	CcSEcCtD
L-DOPA—Back pain—Naltrexone—alcohol dependence	0.000401	0.00248	CcSEcCtD
L-DOPA—Angioedema—Acamprosate—alcohol dependence	0.000401	0.00247	CcSEcCtD
L-DOPA—Muscle spasms—Naltrexone—alcohol dependence	0.000399	0.00246	CcSEcCtD
L-DOPA—Orthostatic hypotension—Citalopram—alcohol dependence	0.000399	0.00246	CcSEcCtD
L-DOPA—DRD1—brain—alcohol dependence	0.000398	0.00517	CbGeAlD
L-DOPA—Dopamine—SLC6A3—alcohol dependence	0.000397	0.118	CrCbGaD
L-DOPA—Malaise—Acamprosate—alcohol dependence	0.000395	0.00244	CcSEcCtD
L-DOPA—Syncope—Acamprosate—alcohol dependence	0.000393	0.00243	CcSEcCtD
L-DOPA—Cramp muscle—Citalopram—alcohol dependence	0.000393	0.00242	CcSEcCtD
L-DOPA—Leukopenia—Acamprosate—alcohol dependence	0.000393	0.00242	CcSEcCtD
L-DOPA—Vision blurred—Naltrexone—alcohol dependence	0.000391	0.00241	CcSEcCtD
L-DOPA—Nasopharyngitis—Citalopram—alcohol dependence	0.00039	0.00241	CcSEcCtD
L-DOPA—Tremor—Naltrexone—alcohol dependence	0.000389	0.0024	CcSEcCtD
L-DOPA—Palpitations—Acamprosate—alcohol dependence	0.000388	0.00239	CcSEcCtD
L-DOPA—Gastritis—Citalopram—alcohol dependence	0.000386	0.00238	CcSEcCtD
L-DOPA—Loss of consciousness—Acamprosate—alcohol dependence	0.000385	0.00238	CcSEcCtD
L-DOPA—Ill-defined disorder—Naltrexone—alcohol dependence	0.000385	0.00237	CcSEcCtD
L-DOPA—Cough—Acamprosate—alcohol dependence	0.000383	0.00236	CcSEcCtD
L-DOPA—Agitation—Naltrexone—alcohol dependence	0.000381	0.00235	CcSEcCtD
L-DOPA—Convulsion—Acamprosate—alcohol dependence	0.00038	0.00234	CcSEcCtD
L-DOPA—Angioedema—Naltrexone—alcohol dependence	0.000379	0.00234	CcSEcCtD
L-DOPA—Hypertension—Acamprosate—alcohol dependence	0.000379	0.00234	CcSEcCtD
L-DOPA—Dysphagia—Citalopram—alcohol dependence	0.000377	0.00233	CcSEcCtD
L-DOPA—DRD2—midbrain—alcohol dependence	0.000375	0.00486	CbGeAlD
L-DOPA—Malaise—Naltrexone—alcohol dependence	0.000374	0.00231	CcSEcCtD
L-DOPA—Chest pain—Acamprosate—alcohol dependence	0.000373	0.0023	CcSEcCtD
L-DOPA—Syncope—Naltrexone—alcohol dependence	0.000372	0.0023	CcSEcCtD
L-DOPA—Anxiety—Acamprosate—alcohol dependence	0.000372	0.0023	CcSEcCtD
L-DOPA—Discomfort—Acamprosate—alcohol dependence	0.000369	0.00228	CcSEcCtD
L-DOPA—Sweating increased—Citalopram—alcohol dependence	0.000368	0.00227	CcSEcCtD
L-DOPA—Angina pectoris—Citalopram—alcohol dependence	0.000368	0.00227	CcSEcCtD
L-DOPA—Palpitations—Naltrexone—alcohol dependence	0.000367	0.00226	CcSEcCtD
L-DOPA—Dry mouth—Acamprosate—alcohol dependence	0.000365	0.00225	CcSEcCtD
L-DOPA—Loss of consciousness—Naltrexone—alcohol dependence	0.000365	0.00225	CcSEcCtD
L-DOPA—Cough—Naltrexone—alcohol dependence	0.000362	0.00223	CcSEcCtD
L-DOPA—Confusional state—Acamprosate—alcohol dependence	0.000361	0.00223	CcSEcCtD
L-DOPA—Convulsion—Naltrexone—alcohol dependence	0.00036	0.00222	CcSEcCtD
L-DOPA—Hypertension—Naltrexone—alcohol dependence	0.000358	0.00221	CcSEcCtD
L-DOPA—Chest pain—Naltrexone—alcohol dependence	0.000353	0.00218	CcSEcCtD
L-DOPA—CYP2D6—brainstem—alcohol dependence	0.000353	0.00458	CbGeAlD
L-DOPA—Shock—Acamprosate—alcohol dependence	0.000352	0.00217	CcSEcCtD
L-DOPA—Anxiety—Naltrexone—alcohol dependence	0.000352	0.00217	CcSEcCtD
L-DOPA—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000351	0.00216	CcSEcCtD
L-DOPA—Thrombocytopenia—Acamprosate—alcohol dependence	0.00035	0.00216	CcSEcCtD
L-DOPA—Discomfort—Naltrexone—alcohol dependence	0.000349	0.00215	CcSEcCtD
L-DOPA—Pollakiuria—Citalopram—alcohol dependence	0.000349	0.00215	CcSEcCtD
L-DOPA—Hyperhidrosis—Acamprosate—alcohol dependence	0.000346	0.00213	CcSEcCtD
L-DOPA—Dry mouth—Naltrexone—alcohol dependence	0.000345	0.00213	CcSEcCtD
L-DOPA—Weight increased—Citalopram—alcohol dependence	0.000343	0.00212	CcSEcCtD
L-DOPA—Confusional state—Naltrexone—alcohol dependence	0.000341	0.00211	CcSEcCtD
L-DOPA—Weight decreased—Citalopram—alcohol dependence	0.000341	0.00211	CcSEcCtD
L-DOPA—Anorexia—Acamprosate—alcohol dependence	0.000341	0.0021	CcSEcCtD
L-DOPA—CYP2D6—forebrain—alcohol dependence	0.000341	0.00442	CbGeAlD
L-DOPA—Oedema—Naltrexone—alcohol dependence	0.000339	0.00209	CcSEcCtD
L-DOPA—Depression—Citalopram—alcohol dependence	0.000335	0.00207	CcSEcCtD
L-DOPA—Hypotension—Acamprosate—alcohol dependence	0.000334	0.00206	CcSEcCtD
L-DOPA—Shock—Naltrexone—alcohol dependence	0.000333	0.00206	CcSEcCtD
L-DOPA—Acute coronary syndrome—Citalopram—alcohol dependence	0.000332	0.00205	CcSEcCtD
L-DOPA—Myocardial infarction—Citalopram—alcohol dependence	0.00033	0.00203	CcSEcCtD
L-DOPA—Neuropathy peripheral—Citalopram—alcohol dependence	0.00033	0.00203	CcSEcCtD
L-DOPA—DRD2—endocrine gland—alcohol dependence	0.000329	0.00427	CbGeAlD
L-DOPA—Hyperhidrosis—Naltrexone—alcohol dependence	0.000327	0.00202	CcSEcCtD
L-DOPA—Urinary tract infection—Citalopram—alcohol dependence	0.000327	0.00202	CcSEcCtD
L-DOPA—Insomnia—Acamprosate—alcohol dependence	0.000324	0.002	CcSEcCtD
L-DOPA—Anorexia—Naltrexone—alcohol dependence	0.000323	0.00199	CcSEcCtD
L-DOPA—Paraesthesia—Acamprosate—alcohol dependence	0.000321	0.00198	CcSEcCtD
L-DOPA—Dyspnoea—Acamprosate—alcohol dependence	0.000319	0.00197	CcSEcCtD
L-DOPA—Somnolence—Acamprosate—alcohol dependence	0.000318	0.00196	CcSEcCtD
L-DOPA—Norepinephrine—DRD2—alcohol dependence	0.000318	0.0942	CrCbGaD
L-DOPA—Dyspepsia—Acamprosate—alcohol dependence	0.000315	0.00194	CcSEcCtD
L-DOPA—Agranulocytosis—Citalopram—alcohol dependence	0.000314	0.00194	CcSEcCtD
L-DOPA—DRD2—testis—alcohol dependence	0.000314	0.00407	CbGeAlD
L-DOPA—Decreased appetite—Acamprosate—alcohol dependence	0.000311	0.00192	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000309	0.00191	CcSEcCtD
L-DOPA—DRD2—nervous system—alcohol dependence	0.000308	0.00399	CbGeAlD
L-DOPA—Insomnia—Naltrexone—alcohol dependence	0.000306	0.00189	CcSEcCtD
L-DOPA—Constipation—Acamprosate—alcohol dependence	0.000306	0.00189	CcSEcCtD
L-DOPA—Pain—Acamprosate—alcohol dependence	0.000306	0.00189	CcSEcCtD
L-DOPA—Paraesthesia—Naltrexone—alcohol dependence	0.000304	0.00188	CcSEcCtD
L-DOPA—Haemoglobin—Citalopram—alcohol dependence	0.000304	0.00187	CcSEcCtD
L-DOPA—Rhinitis—Citalopram—alcohol dependence	0.000303	0.00187	CcSEcCtD
L-DOPA—Haemorrhage—Citalopram—alcohol dependence	0.000302	0.00186	CcSEcCtD
L-DOPA—Dyspnoea—Naltrexone—alcohol dependence	0.000302	0.00186	CcSEcCtD
L-DOPA—Somnolence—Naltrexone—alcohol dependence	0.000301	0.00186	CcSEcCtD
L-DOPA—Hypoaesthesia—Citalopram—alcohol dependence	0.000301	0.00185	CcSEcCtD
L-DOPA—Hallucination—Citalopram—alcohol dependence	0.000301	0.00185	CcSEcCtD
L-DOPA—Urinary tract disorder—Citalopram—alcohol dependence	0.000298	0.00184	CcSEcCtD
L-DOPA—Dopamine—SLC6A4—alcohol dependence	0.000297	0.088	CrCbGaD
L-DOPA—DRD2—central nervous system—alcohol dependence	0.000296	0.00384	CbGeAlD
L-DOPA—Urethral disorder—Citalopram—alcohol dependence	0.000296	0.00183	CcSEcCtD
L-DOPA—Dopamine—DRD2—alcohol dependence	0.000295	0.0875	CrCbGaD
L-DOPA—Feeling abnormal—Acamprosate—alcohol dependence	0.000295	0.00182	CcSEcCtD
L-DOPA—Decreased appetite—Naltrexone—alcohol dependence	0.000294	0.00182	CcSEcCtD
L-DOPA—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000293	0.00181	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000292	0.0018	CcSEcCtD
L-DOPA—Fatigue—Naltrexone—alcohol dependence	0.000292	0.0018	CcSEcCtD
L-DOPA—DRD2—cerebellum—alcohol dependence	0.00029	0.00376	CbGeAlD
L-DOPA—Pain—Naltrexone—alcohol dependence	0.00029	0.00179	CcSEcCtD
L-DOPA—Constipation—Naltrexone—alcohol dependence	0.00029	0.00179	CcSEcCtD
L-DOPA—Urticaria—Acamprosate—alcohol dependence	0.000284	0.00175	CcSEcCtD
L-DOPA—Abdominal pain—Acamprosate—alcohol dependence	0.000283	0.00175	CcSEcCtD
L-DOPA—Flushing—Citalopram—alcohol dependence	0.00028	0.00173	CcSEcCtD
L-DOPA—Feeling abnormal—Naltrexone—alcohol dependence	0.000279	0.00172	CcSEcCtD
L-DOPA—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000277	0.00171	CcSEcCtD
L-DOPA—Arrhythmia—Citalopram—alcohol dependence	0.00027	0.00166	CcSEcCtD
L-DOPA—Urticaria—Naltrexone—alcohol dependence	0.000269	0.00166	CcSEcCtD
L-DOPA—Abdominal pain—Naltrexone—alcohol dependence	0.000268	0.00165	CcSEcCtD
L-DOPA—Alopecia—Citalopram—alcohol dependence	0.000267	0.00165	CcSEcCtD
L-DOPA—Mental disorder—Citalopram—alcohol dependence	0.000265	0.00163	CcSEcCtD
L-DOPA—Hypersensitivity—Acamprosate—alcohol dependence	0.000264	0.00163	CcSEcCtD
L-DOPA—Flatulence—Citalopram—alcohol dependence	0.000259	0.0016	CcSEcCtD
L-DOPA—Tension—Citalopram—alcohol dependence	0.000258	0.00159	CcSEcCtD
L-DOPA—Dysgeusia—Citalopram—alcohol dependence	0.000257	0.00159	CcSEcCtD
L-DOPA—Asthenia—Acamprosate—alcohol dependence	0.000257	0.00158	CcSEcCtD
L-DOPA—Nervousness—Citalopram—alcohol dependence	0.000255	0.00158	CcSEcCtD
L-DOPA—Back pain—Citalopram—alcohol dependence	0.000254	0.00157	CcSEcCtD
L-DOPA—Pruritus—Acamprosate—alcohol dependence	0.000253	0.00156	CcSEcCtD
L-DOPA—Muscle spasms—Citalopram—alcohol dependence	0.000253	0.00156	CcSEcCtD
L-DOPA—Hypersensitivity—Naltrexone—alcohol dependence	0.00025	0.00154	CcSEcCtD
L-DOPA—Vision blurred—Citalopram—alcohol dependence	0.000248	0.00153	CcSEcCtD
L-DOPA—Tremor—Citalopram—alcohol dependence	0.000246	0.00152	CcSEcCtD
L-DOPA—Diarrhoea—Acamprosate—alcohol dependence	0.000245	0.00151	CcSEcCtD
L-DOPA—Ill-defined disorder—Citalopram—alcohol dependence	0.000244	0.0015	CcSEcCtD
L-DOPA—Anaemia—Citalopram—alcohol dependence	0.000243	0.0015	CcSEcCtD
L-DOPA—Asthenia—Naltrexone—alcohol dependence	0.000243	0.0015	CcSEcCtD
L-DOPA—Agitation—Citalopram—alcohol dependence	0.000242	0.00149	CcSEcCtD
L-DOPA—Angioedema—Citalopram—alcohol dependence	0.00024	0.00148	CcSEcCtD
L-DOPA—Pruritus—Naltrexone—alcohol dependence	0.00024	0.00148	CcSEcCtD
L-DOPA—CYP2D6—digestive system—alcohol dependence	0.000239	0.0031	CbGeAlD
L-DOPA—Malaise—Citalopram—alcohol dependence	0.000237	0.00146	CcSEcCtD
L-DOPA—Dizziness—Acamprosate—alcohol dependence	0.000237	0.00146	CcSEcCtD
L-DOPA—Syncope—Citalopram—alcohol dependence	0.000236	0.00145	CcSEcCtD
L-DOPA—Leukopenia—Citalopram—alcohol dependence	0.000235	0.00145	CcSEcCtD
L-DOPA—DRD2—brain—alcohol dependence	0.000235	0.00305	CbGeAlD
L-DOPA—Palpitations—Citalopram—alcohol dependence	0.000232	0.00143	CcSEcCtD
L-DOPA—Diarrhoea—Naltrexone—alcohol dependence	0.000232	0.00143	CcSEcCtD
L-DOPA—Loss of consciousness—Citalopram—alcohol dependence	0.000231	0.00143	CcSEcCtD
L-DOPA—Cough—Citalopram—alcohol dependence	0.000229	0.00142	CcSEcCtD
L-DOPA—CYP2D6—blood—alcohol dependence	0.000228	0.00296	CbGeAlD
L-DOPA—Convulsion—Citalopram—alcohol dependence	0.000228	0.00141	CcSEcCtD
L-DOPA—Vomiting—Acamprosate—alcohol dependence	0.000228	0.0014	CcSEcCtD
L-DOPA—Hypertension—Citalopram—alcohol dependence	0.000227	0.0014	CcSEcCtD
L-DOPA—Rash—Acamprosate—alcohol dependence	0.000226	0.00139	CcSEcCtD
L-DOPA—Dermatitis—Acamprosate—alcohol dependence	0.000225	0.00139	CcSEcCtD
L-DOPA—Headache—Acamprosate—alcohol dependence	0.000224	0.00138	CcSEcCtD
L-DOPA—Dizziness—Naltrexone—alcohol dependence	0.000224	0.00138	CcSEcCtD
L-DOPA—Chest pain—Citalopram—alcohol dependence	0.000224	0.00138	CcSEcCtD
L-DOPA—Anxiety—Citalopram—alcohol dependence	0.000223	0.00138	CcSEcCtD
L-DOPA—Discomfort—Citalopram—alcohol dependence	0.000221	0.00136	CcSEcCtD
L-DOPA—Dry mouth—Citalopram—alcohol dependence	0.000219	0.00135	CcSEcCtD
L-DOPA—Confusional state—Citalopram—alcohol dependence	0.000216	0.00133	CcSEcCtD
L-DOPA—Vomiting—Naltrexone—alcohol dependence	0.000215	0.00133	CcSEcCtD
L-DOPA—Oedema—Citalopram—alcohol dependence	0.000215	0.00132	CcSEcCtD
L-DOPA—Rash—Naltrexone—alcohol dependence	0.000214	0.00132	CcSEcCtD
L-DOPA—Dermatitis—Naltrexone—alcohol dependence	0.000213	0.00132	CcSEcCtD
L-DOPA—Nausea—Acamprosate—alcohol dependence	0.000213	0.00131	CcSEcCtD
L-DOPA—Headache—Naltrexone—alcohol dependence	0.000212	0.00131	CcSEcCtD
L-DOPA—Shock—Citalopram—alcohol dependence	0.000211	0.0013	CcSEcCtD
L-DOPA—Thrombocytopenia—Citalopram—alcohol dependence	0.00021	0.0013	CcSEcCtD
L-DOPA—Hyperhidrosis—Citalopram—alcohol dependence	0.000207	0.00128	CcSEcCtD
L-DOPA—Anorexia—Citalopram—alcohol dependence	0.000205	0.00126	CcSEcCtD
L-DOPA—Nausea—Naltrexone—alcohol dependence	0.000201	0.00124	CcSEcCtD
L-DOPA—Hypotension—Citalopram—alcohol dependence	0.0002	0.00124	CcSEcCtD
L-DOPA—CYP2D6—endocrine gland—alcohol dependence	0.000198	0.00256	CbGeAlD
L-DOPA—Insomnia—Citalopram—alcohol dependence	0.000194	0.0012	CcSEcCtD
L-DOPA—Paraesthesia—Citalopram—alcohol dependence	0.000193	0.00119	CcSEcCtD
L-DOPA—Dyspnoea—Citalopram—alcohol dependence	0.000191	0.00118	CcSEcCtD
L-DOPA—Somnolence—Citalopram—alcohol dependence	0.000191	0.00118	CcSEcCtD
L-DOPA—Dyspepsia—Citalopram—alcohol dependence	0.000189	0.00117	CcSEcCtD
L-DOPA—CYP2D6—testis—alcohol dependence	0.000188	0.00244	CbGeAlD
L-DOPA—Decreased appetite—Citalopram—alcohol dependence	0.000187	0.00115	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000185	0.00114	CcSEcCtD
L-DOPA—CYP2D6—nervous system—alcohol dependence	0.000185	0.0024	CbGeAlD
L-DOPA—Fatigue—Citalopram—alcohol dependence	0.000185	0.00114	CcSEcCtD
L-DOPA—Pain—Citalopram—alcohol dependence	0.000183	0.00113	CcSEcCtD
L-DOPA—Constipation—Citalopram—alcohol dependence	0.000183	0.00113	CcSEcCtD
L-DOPA—CYP2D6—liver—alcohol dependence	0.000178	0.00231	CbGeAlD
L-DOPA—CYP2D6—central nervous system—alcohol dependence	0.000178	0.00231	CbGeAlD
L-DOPA—Feeling abnormal—Citalopram—alcohol dependence	0.000177	0.00109	CcSEcCtD
L-DOPA—Gastrointestinal pain—Citalopram—alcohol dependence	0.000175	0.00108	CcSEcCtD
L-DOPA—CYP2D6—cerebellum—alcohol dependence	0.000174	0.00226	CbGeAlD
L-DOPA—Urticaria—Citalopram—alcohol dependence	0.00017	0.00105	CcSEcCtD
L-DOPA—Abdominal pain—Citalopram—alcohol dependence	0.00017	0.00105	CcSEcCtD
L-DOPA—Hypersensitivity—Citalopram—alcohol dependence	0.000158	0.000975	CcSEcCtD
L-DOPA—Asthenia—Citalopram—alcohol dependence	0.000154	0.00095	CcSEcCtD
L-DOPA—Pruritus—Citalopram—alcohol dependence	0.000152	0.000936	CcSEcCtD
L-DOPA—Diarrhoea—Citalopram—alcohol dependence	0.000147	0.000906	CcSEcCtD
L-DOPA—Dizziness—Citalopram—alcohol dependence	0.000142	0.000875	CcSEcCtD
L-DOPA—CYP2D6—brain—alcohol dependence	0.000141	0.00183	CbGeAlD
L-DOPA—Vomiting—Citalopram—alcohol dependence	0.000136	0.000842	CcSEcCtD
L-DOPA—Rash—Citalopram—alcohol dependence	0.000135	0.000835	CcSEcCtD
L-DOPA—Dermatitis—Citalopram—alcohol dependence	0.000135	0.000834	CcSEcCtD
L-DOPA—Headache—Citalopram—alcohol dependence	0.000134	0.000829	CcSEcCtD
L-DOPA—Nausea—Citalopram—alcohol dependence	0.000127	0.000786	CcSEcCtD
L-DOPA—DRD5—GPCR downstream signaling—HTR7—alcohol dependence	4.67e-05	0.000379	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—POMC—alcohol dependence	4.62e-05	0.000375	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—AVP—alcohol dependence	4.62e-05	0.000375	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CHRM2—alcohol dependence	4.61e-05	0.000374	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	4.58e-05	0.000371	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—AVP—alcohol dependence	4.56e-05	0.00037	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—DRD4—alcohol dependence	4.55e-05	0.000369	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CRHR1—alcohol dependence	4.51e-05	0.000366	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—OPRD1—alcohol dependence	4.5e-05	0.000365	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	4.48e-05	0.000363	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CRHR1—alcohol dependence	4.45e-05	0.000361	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—OPRK1—alcohol dependence	4.45e-05	0.000361	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	4.45e-05	0.000361	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—DRD4—alcohol dependence	4.45e-05	0.000361	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—MAOA—alcohol dependence	4.4e-05	0.000357	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—OPRK1—alcohol dependence	4.39e-05	0.000356	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—NPY—alcohol dependence	4.38e-05	0.000356	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CNR1—alcohol dependence	4.34e-05	0.000352	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—OPRM1—alcohol dependence	4.32e-05	0.000351	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PDYN—alcohol dependence	4.31e-05	0.00035	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—OPRM1—alcohol dependence	4.29e-05	0.000348	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—HTR2A—alcohol dependence	4.27e-05	0.000346	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CNR1—alcohol dependence	4.24e-05	0.000344	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CHRM2—alcohol dependence	4.24e-05	0.000344	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—DRD2—alcohol dependence	4.24e-05	0.000344	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HTR7—alcohol dependence	4.24e-05	0.000344	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—EP300—alcohol dependence	4.23e-05	0.000343	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—OPRM1—alcohol dependence	4.23e-05	0.000343	CbGpPWpGaD
L-DOPA—DDC—Metabolism—GOT2—alcohol dependence	4.23e-05	0.000343	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CRH—alcohol dependence	4.23e-05	0.000343	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR1B—alcohol dependence	4.23e-05	0.000343	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—OPRD1—alcohol dependence	4.21e-05	0.000341	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CHRM2—alcohol dependence	4.18e-05	0.00034	CbGpPWpGaD
L-DOPA—PSIP1—Disease—EP300—alcohol dependence	4.15e-05	0.000336	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HTR7—alcohol dependence	4.14e-05	0.000336	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PDYN—alcohol dependence	4.03e-05	0.000327	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	4.03e-05	0.000327	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CRHR1—alcohol dependence	4.01e-05	0.000325	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—WASF2—alcohol dependence	4.01e-05	0.000325	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—NPY—alcohol dependence	3.98e-05	0.000323	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CYP2E1—alcohol dependence	3.98e-05	0.000323	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	3.98e-05	0.000323	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—NPY—alcohol dependence	3.95e-05	0.00032	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—AVP—alcohol dependence	3.93e-05	0.000319	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—OPRM1—alcohol dependence	3.89e-05	0.000316	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—NPY—alcohol dependence	3.89e-05	0.000316	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—WASF1—alcohol dependence	3.84e-05	0.000312	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HTR2A—alcohol dependence	3.84e-05	0.000312	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—OPRM1—alcohol dependence	3.84e-05	0.000312	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CRH—alcohol dependence	3.84e-05	0.000312	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR1B—alcohol dependence	3.84e-05	0.000312	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—POMC—alcohol dependence	3.83e-05	0.00031	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—OPRD1—alcohol dependence	3.82e-05	0.00031	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—EP300—alcohol dependence	3.81e-05	0.000309	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	3.81e-05	0.000309	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR1B—alcohol dependence	3.81e-05	0.000309	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CRH—alcohol dependence	3.81e-05	0.000309	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HTR2A—alcohol dependence	3.79e-05	0.000308	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CHRM2—alcohol dependence	3.77e-05	0.000306	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—EP300—alcohol dependence	3.76e-05	0.000305	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR1B—alcohol dependence	3.76e-05	0.000305	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CRH—alcohol dependence	3.76e-05	0.000305	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CRHR1—alcohol dependence	3.75e-05	0.000304	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PDYN—alcohol dependence	3.66e-05	0.000297	CbGpPWpGaD
L-DOPA—DDC—Metabolism—GOT1—alcohol dependence	3.65e-05	0.000296	CbGpPWpGaD
L-DOPA—DDC—Metabolism—GGT1—alcohol dependence	3.65e-05	0.000296	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—NPY—alcohol dependence	3.58e-05	0.000291	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—AVP—alcohol dependence	3.57e-05	0.000289	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—NPY—alcohol dependence	3.54e-05	0.000287	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CNR1—alcohol dependence	3.53e-05	0.000286	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CHRM2—alcohol dependence	3.53e-05	0.000286	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—AVP—alcohol dependence	3.49e-05	0.000283	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—OPRM1—alcohol dependence	3.46e-05	0.000281	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CRH—alcohol dependence	3.46e-05	0.000281	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR1B—alcohol dependence	3.46e-05	0.000281	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—DRD2—alcohol dependence	3.44e-05	0.000279	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR7—alcohol dependence	3.44e-05	0.000279	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR1B—alcohol dependence	3.41e-05	0.000277	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CRH—alcohol dependence	3.41e-05	0.000277	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—POMC—alcohol dependence	3.41e-05	0.000277	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CRHR1—alcohol dependence	3.41e-05	0.000276	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—OPRK1—alcohol dependence	3.36e-05	0.000272	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—DRD4—alcohol dependence	3.33e-05	0.00027	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—OPRD1—alcohol dependence	3.32e-05	0.000269	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—DRD4—alcohol dependence	3.28e-05	0.000266	CbGpPWpGaD
L-DOPA—DDC—Metabolism—MAOA—alcohol dependence	3.27e-05	0.000266	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HTR2A—alcohol dependence	3.27e-05	0.000265	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—OPRM1—alcohol dependence	3.24e-05	0.000263	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CNR1—alcohol dependence	3.2e-05	0.00026	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CHRM2—alcohol dependence	3.2e-05	0.00026	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NPY—alcohol dependence	3.19e-05	0.000258	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PDYN—alcohol dependence	3.18e-05	0.000258	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CNR1—alcohol dependence	3.18e-05	0.000258	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CNR1—alcohol dependence	3.13e-05	0.000254	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR7—alcohol dependence	3.13e-05	0.000254	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—DRD2—alcohol dependence	3.13e-05	0.000254	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR7—alcohol dependence	3.1e-05	0.000252	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—DRD2—alcohol dependence	3.1e-05	0.000252	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADH6—alcohol dependence	3.09e-05	0.000251	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR1B—alcohol dependence	3.07e-05	0.000249	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CRH—alcohol dependence	3.07e-05	0.000249	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—POMC—alcohol dependence	3.07e-05	0.000249	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—DRD2—alcohol dependence	3.06e-05	0.000248	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR7—alcohol dependence	3.06e-05	0.000248	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	3.04e-05	0.000247	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—POMC—alcohol dependence	3.03e-05	0.000246	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—DRD4—alcohol dependence	3.02e-05	0.000245	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—OPRD1—alcohol dependence	2.99e-05	0.000243	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—DRD4—alcohol dependence	2.98e-05	0.000242	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—NPY—alcohol dependence	2.98e-05	0.000242	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HTR2A—alcohol dependence	2.97e-05	0.000241	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—WASF2—alcohol dependence	2.96e-05	0.00024	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CRHR1—alcohol dependence	2.96e-05	0.00024	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—OPRD1—alcohol dependence	2.95e-05	0.000239	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—OPRM1—alcohol dependence	2.94e-05	0.000239	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HTR2A—alcohol dependence	2.9e-05	0.000235	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—AVP—alcohol dependence	2.9e-05	0.000235	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CNR1—alcohol dependence	2.89e-05	0.000234	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—EP300—alcohol dependence	2.88e-05	0.000233	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CRH—alcohol dependence	2.87e-05	0.000233	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR1B—alcohol dependence	2.87e-05	0.000233	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PDYN—alcohol dependence	2.87e-05	0.000233	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—POMC—alcohol dependence	2.86e-05	0.000232	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CNR1—alcohol dependence	2.85e-05	0.000231	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—WASF1—alcohol dependence	2.84e-05	0.00023	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PDYN—alcohol dependence	2.83e-05	0.000229	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—DRD2—alcohol dependence	2.81e-05	0.000228	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR7—alcohol dependence	2.81e-05	0.000228	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CHRM2—alcohol dependence	2.78e-05	0.000226	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—DRD2—alcohol dependence	2.78e-05	0.000225	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR7—alcohol dependence	2.78e-05	0.000225	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—NPY—alcohol dependence	2.71e-05	0.00022	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—DRD4—alcohol dependence	2.69e-05	0.000218	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CRHR1—alcohol dependence	2.66e-05	0.000216	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—WASF2—alcohol dependence	2.66e-05	0.000216	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—AVP—alcohol dependence	2.63e-05	0.000214	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CRHR1—alcohol dependence	2.63e-05	0.000213	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—WASF2—alcohol dependence	2.63e-05	0.000213	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CRH—alcohol dependence	2.61e-05	0.000212	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR1B—alcohol dependence	2.61e-05	0.000212	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—POMC—alcohol dependence	2.61e-05	0.000212	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—AVP—alcohol dependence	2.61e-05	0.000212	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—AVP—alcohol dependence	2.57e-05	0.000209	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CNR1—alcohol dependence	2.57e-05	0.000208	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADH1A—alcohol dependence	2.56e-05	0.000208	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—OPRM1—alcohol dependence	2.55e-05	0.000207	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—WASF1—alcohol dependence	2.55e-05	0.000207	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—WASF1—alcohol dependence	2.52e-05	0.000205	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—DRD4—alcohol dependence	2.51e-05	0.000204	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CHRM2—alcohol dependence	2.51e-05	0.000203	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR7—alcohol dependence	2.5e-05	0.000203	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—DRD2—alcohol dependence	2.5e-05	0.000203	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CHRM2—alcohol dependence	2.47e-05	0.000201	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR2A—alcohol dependence	2.41e-05	0.000196	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CNR1—alcohol dependence	2.4e-05	0.000195	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—POMC—alcohol dependence	2.37e-05	0.000192	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—AVP—alcohol dependence	2.37e-05	0.000192	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NPY—alcohol dependence	2.35e-05	0.000191	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR7—alcohol dependence	2.34e-05	0.00019	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—AVP—alcohol dependence	2.34e-05	0.00019	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—POMC—alcohol dependence	2.32e-05	0.000188	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—OPRM1—alcohol dependence	2.3e-05	0.000187	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—DRD4—alcohol dependence	2.28e-05	0.000185	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—OPRM1—alcohol dependence	2.27e-05	0.000184	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CRH—alcohol dependence	2.27e-05	0.000184	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR1B—alcohol dependence	2.27e-05	0.000184	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—OPRD1—alcohol dependence	2.26e-05	0.000183	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR2A—alcohol dependence	2.19e-05	0.000178	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CNR1—alcohol dependence	2.18e-05	0.000177	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADH4—alcohol dependence	2.18e-05	0.000177	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR2A—alcohol dependence	2.17e-05	0.000176	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PDYN—alcohol dependence	2.16e-05	0.000176	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR2A—alcohol dependence	2.14e-05	0.000174	CbGpPWpGaD
L-DOPA—DDC—Metabolism—POMC—alcohol dependence	2.13e-05	0.000173	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR7—alcohol dependence	2.13e-05	0.000172	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NPY—alcohol dependence	2.12e-05	0.000172	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—AVP—alcohol dependence	2.11e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NPY—alcohol dependence	2.09e-05	0.000169	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CRH—alcohol dependence	2.04e-05	0.000166	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR1B—alcohol dependence	2.04e-05	0.000166	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CRH—alcohol dependence	2.01e-05	0.000163	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR1B—alcohol dependence	2.01e-05	0.000163	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—WASF2—alcohol dependence	2.01e-05	0.000163	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CRHR1—alcohol dependence	2.01e-05	0.000163	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR2A—alcohol dependence	1.97e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—AVP—alcohol dependence	1.97e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR2A—alcohol dependence	1.95e-05	0.000158	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—WASF1—alcohol dependence	1.93e-05	0.000156	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—POMC—alcohol dependence	1.93e-05	0.000156	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CNR1—alcohol dependence	1.89e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CHRM2—alcohol dependence	1.89e-05	0.000153	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADH7—alcohol dependence	1.85e-05	0.00015	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DRD2—alcohol dependence	1.85e-05	0.00015	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR7—alcohol dependence	1.85e-05	0.00015	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—AVP—alcohol dependence	1.79e-05	0.000145	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD4—alcohol dependence	1.79e-05	0.000145	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GGT2—alcohol dependence	1.78e-05	0.000144	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD4—alcohol dependence	1.76e-05	0.000143	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR2A—alcohol dependence	1.75e-05	0.000142	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—POMC—alcohol dependence	1.75e-05	0.000142	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—OPRM1—alcohol dependence	1.74e-05	0.000141	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—POMC—alcohol dependence	1.73e-05	0.000141	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—POMC—alcohol dependence	1.71e-05	0.000139	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CNR1—alcohol dependence	1.7e-05	0.000138	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CNR1—alcohol dependence	1.68e-05	0.000136	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD2—alcohol dependence	1.66e-05	0.000135	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR7—alcohol dependence	1.66e-05	0.000135	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR7—alcohol dependence	1.64e-05	0.000133	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD2—alcohol dependence	1.64e-05	0.000133	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR2A—alcohol dependence	1.64e-05	0.000133	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADH1B—alcohol dependence	1.62e-05	0.000132	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NPY—alcohol dependence	1.6e-05	0.00013	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—POMC—alcohol dependence	1.57e-05	0.000128	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—AVP—alcohol dependence	1.55e-05	0.000126	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—POMC—alcohol dependence	1.55e-05	0.000126	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR1B—alcohol dependence	1.54e-05	0.000125	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CRH—alcohol dependence	1.54e-05	0.000125	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2A—alcohol dependence	1.49e-05	0.000121	CbGpPWpGaD
L-DOPA—DDC—Metabolism—EP300—alcohol dependence	1.41e-05	0.000115	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—POMC—alcohol dependence	1.4e-05	0.000114	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—AVP—alcohol dependence	1.4e-05	0.000114	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—AVP—alcohol dependence	1.38e-05	0.000112	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD4—alcohol dependence	1.35e-05	0.000109	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MAOB—alcohol dependence	1.35e-05	0.000109	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—POMC—alcohol dependence	1.31e-05	0.000106	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2A—alcohol dependence	1.29e-05	0.000105	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CNR1—alcohol dependence	1.29e-05	0.000104	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR7—alcohol dependence	1.26e-05	0.000102	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—POMC—alcohol dependence	1.19e-05	9.65e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2A—alcohol dependence	1.16e-05	9.45e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2A—alcohol dependence	1.15e-05	9.32e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALDH2—alcohol dependence	1.14e-05	9.28e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AVP—alcohol dependence	1.06e-05	8.57e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—POMC—alcohol dependence	1.03e-05	8.38e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GOT2—alcohol dependence	9.73e-06	7.89e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—POMC—alcohol dependence	9.3e-06	7.55e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EP300—alcohol dependence	9.29e-06	7.54e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—POMC—alcohol dependence	9.18e-06	7.45e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CYP2E1—alcohol dependence	9.15e-06	7.42e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2A—alcohol dependence	8.79e-06	7.13e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GGT1—alcohol dependence	8.4e-06	6.81e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GOT1—alcohol dependence	8.4e-06	6.81e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MAOA—alcohol dependence	7.52e-06	6.11e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—POMC—alcohol dependence	7.02e-06	5.7e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EP300—alcohol dependence	6.85e-06	5.56e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EP300—alcohol dependence	6.17e-06	5.01e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EP300—alcohol dependence	6.09e-06	4.94e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—POMC—alcohol dependence	4.9e-06	3.98e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EP300—alcohol dependence	4.66e-06	3.78e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—EP300—alcohol dependence	3.25e-06	2.64e-05	CbGpPWpGaD
